These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31942628)

  • 21. HyperIgE in hypomorphic recombination-activating gene defects.
    Castiello MC; Brandas C; Capo V; Villa A
    Curr Opin Immunol; 2023 Feb; 80():102279. PubMed ID: 36529093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency.
    Castiello MC; Bosticardo M; Sacchetti N; Calzoni E; Fontana E; Yamazaki Y; Draghici E; Corsino C; Bortolomai I; Sereni L; Yu HH; Uva P; Palchaudhuri R; Scadden DT; Villa A; Notarangelo LD
    J Allergy Clin Immunol; 2021 Jan; 147(1):309-320.e6. PubMed ID: 32387109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
    Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
    J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.
    Matangkasombut P; Pichavant M; Saez DE; Giliani S; Mazzolari E; Finocchi A; Villa A; Sobacchi C; Cortes P; Umetsu DT; Notarangelo LD
    Blood; 2008 Jan; 111(1):271-4. PubMed ID: 17890453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymus microenvironment in human primary immunodeficiency diseases.
    Poliani PL; Vermi W; Facchetti F
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):489-95. PubMed ID: 19841578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three faces of recombination activating gene 1 (RAG1) mutations.
    Patiroglu T; Akar HH; Van Der Burg M
    Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models.
    Milner JD; Fasth A; Etzioni A
    J Clin Immunol; 2008 May; 28 Suppl 1():S29-33. PubMed ID: 18193342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.
    John T; Walter JE; Schuetz C; Chen K; Abraham RS; Bonfim C; Boyce TG; Joshi AY; Kang E; Carvalho BT; Mahajerin A; Nugent D; Puthenveetil G; Soni A; Su H; Cowan MJ; Notarangelo L; Buchbinder D
    J Clin Immunol; 2016 Oct; 36(7):725-32. PubMed ID: 27539235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innovative Cell-Based Therapies and Conditioning to Cure RAG Deficiency.
    Villa A; Capo V; Castiello MC
    Front Immunol; 2020; 11():607926. PubMed ID: 33329604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approaches to patients with variants in RAG genes: from diagnosis to timely treatment.
    Bulkhi AA; Dasso JF; Schuetz C; Walter JE
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1033-1046. PubMed ID: 31535575
    [No Abstract]   [Full Text] [Related]  

  • 31. Estimated disease incidence of RAG1/2 mutations: A case report and querying the Exome Aggregation Consortium.
    Kumánovics A; Lee YN; Close DW; Coonrod EM; Ujhazi B; Chen K; MacArthur DG; Krivan G; Notarangelo LD; Walter JE
    J Allergy Clin Immunol; 2017 Feb; 139(2):690-692.e3. PubMed ID: 27609655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.
    Dalal I; Tabori U; Bielorai B; Golan H; Rosenthal E; Amariglio N; Rechavi G; Toren A
    Clin Immunol; 2005 Apr; 115(1):70-3. PubMed ID: 15870023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Omenn Syndrome and DNA recombination defects].
    Yachie A
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T-B- SCID in patients with defects in RAG genes.
    Haq IJ; Steinberg LJ; Hoenig M; van der Burg M; Villa A; Cant AJ; Middleton PG; Gennery AR
    Clin Immunol; 2007 Aug; 124(2):165-9. PubMed ID: 17572155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens.
    Geier CB; Piller A; Linder A; Sauerwein KM; Eibl MM; Wolf HM
    PLoS One; 2015; 10(7):e0133220. PubMed ID: 26186701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
    Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
    Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RAG1/2 knockout pigs with severe combined immunodeficiency.
    Huang J; Guo X; Fan N; Song J; Zhao B; Ouyang Z; Liu Z; Zhao Y; Yan Q; Yi X; Schambach A; Frampton J; Esteban MA; Yang D; Yang H; Lai L
    J Immunol; 2014 Aug; 193(3):1496-503. PubMed ID: 24973446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omenn syndrome in the context of other B cell-negative severe combined immunodeficiencies.
    Villa A; Sobacchi C; Vezzoni P
    Isr Med Assoc J; 2002 Mar; 4(3):218-21. PubMed ID: 11908269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tearing RAGs apart.
    Gaspar HB
    Blood; 2014 Jan; 123(2):156-7. PubMed ID: 24408206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.
    Farmer JR; Foldvari Z; Ujhazi B; De Ravin SS; Chen K; Bleesing JJH; Schuetz C; Al-Herz W; Abraham RS; Joshi AY; Costa-Carvalho BT; Buchbinder D; Booth C; Reiff A; Ferguson PJ; Aghamohammadi A; Abolhassani H; Puck JM; Adeli M; Cancrini C; Palma P; Bertaina A; Locatelli F; Di Matteo G; Geha RS; Kanariou MG; Lycopoulou L; Tzanoudaki M; Sleasman JW; Parikh S; Pinero G; Fischer BM; Dbaibo G; Unal E; Patiroglu T; Karakukcu M; Al-Saad KK; Dilley MA; Pai SY; Dutmer CM; Gelfand EW; Geier CB; Eibl MM; Wolf HM; Henderson LA; Hazen MM; Bonfim C; Wolska-Kuśnierz B; Butte MJ; Hernandez JD; Nicholas SK; Stepensky P; Chandrakasan S; Miano M; Westermann-Clark E; Goda V; Kriván G; Holland SM; Fadugba O; Henrickson SE; Ozen A; Karakoc-Aydiner E; Baris S; Kiykim A; Bredius R; Hoeger B; Boztug K; Pashchenko O; Neven B; Moshous D; Villartay JP; Bousfiha AA; Hill HR; Notarangelo LD; Walter JE
    J Allergy Clin Immunol Pract; 2019; 7(6):1970-1985.e4. PubMed ID: 30877075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.